Sophie L Stocker
Overview
Explore the profile of Sophie L Stocker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
1007
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinnappah K, Hughes D, Stocker S, Wright D
Br J Clin Pharmacol
. 2025 Jan;
PMID: 39837562
Aims: An unbiased means of documenting medication-taking is important to ensure quality evidence about adherence research and to accurately identify individuals at risk of suboptimal adherence for the development of...
2.
White-Koning M, Wright D, Hughes D, Michael T, Coleshill M, Aslani P, et al.
Clin Pharmacokinet
. 2024 Dec;
64(1):93-105.
PMID: 39693016
Background And Objective: Adherence to urate-lowering therapy among people with gout is poor, so it is important to understand which day-to-day medication-taking ('implementation') patterns are most likely to lead to...
3.
Milder T, Lin J, Pearson S, Costa J, Neuen B, Pollock C, et al.
Diabetes Obes Metab
. 2024 Nov;
27(2):997-1000.
PMID: 39511848
No abstract available.
4.
Chen R, Nguyen T, Kim H, Stocker S, Alffenaar J
J Antimicrob Chemother
. 2024 Nov;
80(1):254-261.
PMID: 39508356
Introduction: Pyrazinamide, one of the first-line antituberculosis drugs, displays variability in drug exposure that is associated with treatment response. A simple, low-cost assay may be helpful to optimize treatment. This...
5.
Hishe H, Stocker S, Stamp L, Dalbeth N, Merriman T, Wright D
Ther Drug Monit
. 2024 Nov;
47(2):281-288.
PMID: 39503577
Background: Allopurinol dose reduction proportional to creatinine clearance (CLcr) results in suboptimal urate lowering in patients with gout. Similarly, diuretic therapy reduces oxypurinol clearance but is unexpectedly associated with the...
6.
Milder T, Lin J, Pearson S, Greenfield J, Day R, Stocker S, et al.
Br J Clin Pharmacol
. 2024 Sep;
91(1):117-126.
PMID: 39224963
Aims: The aim of this study was to examine contemporary trends in the use of, time to, and type of first add-on anti-hyperglycaemic therapy to metformin in Australia. Methods: We...
7.
Nguyen T, Chen R, Hawkins B, Hibbs D, Kim H, Wheate N, et al.
Clin Pharmacokinet
. 2024 Jul;
63(8):1067-1087.
PMID: 39008243
Background And Objectives: Saliva is a patient-friendly matrix for therapeutic drug monitoring (TDM) but is infrequently used in routine care. This is due to the uncertainty of saliva-based TDM results...
8.
Carland J, Carland D, Brett J, Stocker S, Roberts D, Day R, et al.
Br J Clin Pharmacol
. 2024 Jul;
90(9):2038-2066.
PMID: 38984480
Aims: Therapeutic drug monitoring (TDM) aims to optimize drug therapy. As demand on health resources increases, and the technology underpinning TDM becomes more sophisticated, the economic benefits of TDM in...
9.
Wehbe E, Patanwala A, Lu C, Kim H, Stocker S, Alffenaar J
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794338
Due to variability in pharmacokinetics and pharmacodynamics, clinical outcomes of antimicrobial drug therapy vary between patients. As such, personalised medication management, considering both pharmacokinetics and pharmacodynamics, is a growing concept...
10.
Michael T, Chan J, Hughes S, Wright D, Coleshill M, Hughes D, et al.
Health Expect
. 2024 May;
27(3):e14071.
PMID: 38742836
Introduction: Gout management remains suboptimal despite safe and effective urate-lowering therapy. Self-monitoring of urate may improve gout management, however, the acceptability of urate self-monitoring by people with gout is unknown....